-
Something wrong with this record ?
The influence of endothelin-A receptor gene polymorphism on the progression of Autosomal dominant polycystic kidney disease and IgA nephropathy
Jana Reiterová, Miroslav Merta, Jitka Štekrová, Dita Maixnerová, H. Obeidová, Věra Kebrdlová, Ondřej Viklický, Vladimír Tesař
Language English Country Czech Republic
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Research Support as Topic MeSH
- Genotype MeSH
- Glomerulonephritis, IGA genetics MeSH
- Polymorphism, Single Nucleotide MeSH
- Humans MeSH
- Polycystic Kidney, Autosomal Dominant genetics MeSH
- Disease Progression MeSH
- Receptor, Endothelin A genetics MeSH
- Aged MeSH
- Age Distribution MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
ADPKD is the most common hereditary renal disease. IGAN is a mesangial proliferative glomerulonephritis characterized by diffuse mesangial deposition of immunoglobulin A. ET-1 has been suggested to be a major disease-promoting factor in renal diseases. The vasoconstrictor effect of ET-1 is mediated by the ET-A receptor. We have investigated the influence of C/T polymorphism in exon 8 of the EDNRA gene. A total number of 193 patients (87 males, 106 females) with ADPKD entered into this study. Patients were divided into three groups: 1. 47 pts with ESRD later than in 63 years (slow progressors), 2. 49 pts with ESRD before 45 (rapid progressors) and 3. 97 pts with ESRD between 45–63 years. Moreover, we examined a group of 153 pts with histologically proven IGAN (116 males, 37 females). Pts were divided into two groups: 1. 79 pts with ERSD during 5 years of the study (IGAN rapid progressors) and 2. 74 patients with normal renal function (IGAN slow progressors). As a control group we used 100 genetically unrelated healthy subjects. The distribution of C/T polymorphism did not significantly differ between rapid and slow progressors of ADPKD and IGAN. The comparison of ESRD ages showed that CC females with ADPKD failed significantly later than CT heterozygotes: CC (57.4 ± 8.1 years), CT (53.0 ± 9.1 years) and TT (54.5 ± 6.4years) (t-test, P = 0.018). To conclude, the CC genotype could be protective in ADPKD females. This genotype was described to be associated with lower pulse pressure.
Grant č. 0021620806 Ministerstvo školství, mládeže a tělovýchovy -- Grant č. NR/9523 Ministerstvo zdravotnictví
Bibliography, etc.Lit.: 26
- 000
- 03898naa 2200505 a 4500
- 001
- bmc07502377
- 003
- CZ-PrNML
- 005
- 20111210121424.0
- 008
- 080314s2007 xr e eng||
- 009
- AR
- 035 __
- $a (PubMed)17706018
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Reiterová, Jana $7 xx0018667
- 245 14
- $a The influence of endothelin-A receptor gene polymorphism on the progression of Autosomal dominant polycystic kidney disease and IgA nephropathy / $c Jana Reiterová, Miroslav Merta, Jitka Štekrová, Dita Maixnerová, H. Obeidová, Věra Kebrdlová, Ondřej Viklický, Vladimír Tesař
- 314 __
- $a Department of Nephrology, Charles University in Prague, 1st Faculty of Medicine, Prague
- 500 __
- $a Grant č. 0021620806 Ministerstvo školství, mládeže a tělovýchovy -- Grant č. NR/9523 Ministerstvo zdravotnictví
- 504 __
- $a Lit.: 26
- 520 9_
- $a ADPKD is the most common hereditary renal disease. IGAN is a mesangial proliferative glomerulonephritis characterized by diffuse mesangial deposition of immunoglobulin A. ET-1 has been suggested to be a major disease-promoting factor in renal diseases. The vasoconstrictor effect of ET-1 is mediated by the ET-A receptor. We have investigated the influence of C/T polymorphism in exon 8 of the EDNRA gene. A total number of 193 patients (87 males, 106 females) with ADPKD entered into this study. Patients were divided into three groups: 1. 47 pts with ESRD later than in 63 years (slow progressors), 2. 49 pts with ESRD before 45 (rapid progressors) and 3. 97 pts with ESRD between 45–63 years. Moreover, we examined a group of 153 pts with histologically proven IGAN (116 males, 37 females). Pts were divided into two groups: 1. 79 pts with ERSD during 5 years of the study (IGAN rapid progressors) and 2. 74 patients with normal renal function (IGAN slow progressors). As a control group we used 100 genetically unrelated healthy subjects. The distribution of C/T polymorphism did not significantly differ between rapid and slow progressors of ADPKD and IGAN. The comparison of ESRD ages showed that CC females with ADPKD failed significantly later than CT heterozygotes: CC (57.4 ± 8.1 years), CT (53.0 ± 9.1 years) and TT (54.5 ± 6.4years) (t-test, P = 0.018). To conclude, the CC genotype could be protective in ADPKD females. This genotype was described to be associated with lower pulse pressure.
- 650 _2
- $a IgA nefropatie $x genetika $7 D005922
- 650 _2
- $a polycystické ledviny autozomálně dominantní $x genetika $7 D016891
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a receptor endotelinu A $x genetika $7 D044022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a věkové rozložení $7 D017677
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a finanční podpora výzkumu jako téma $7 D012109
- 700 1_
- $a Merta, Miroslav, $7 mzk2004248662 $d 1954-
- 700 1_
- $a Štekrová, Jitka $7 xx0061371
- 700 1_
- $a Maixnerová, Dita $7 xx0063141
- 700 1_
- $a Obeidová, H. $7 _BN002400
- 700 1_
- $a Kebrdlová, Věra. $7 _BN002401
- 700 1_
- $a Viklický, Ondřej, $d 1966- $7 nlk20050170291
- 700 1_
- $a Tesař, Vladimír, $d 1957- $7 jn20000402349
- 773 0_
- $w MED00011004 $t Folia biologica $g Roč. 53, č. 4 (2007), s. 134-137 $x 0015-5500
- 856 41
- $u http://fb.cuni.cz/Data/files/folia_biologica/volume_53_2007_4/FB2007A0019.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 1
- 990 __
- $a 20080314093713 $b ABA008
- 991 __
- $a 20080724154945 $b ABA008
- 999 __
- $a ok $b bmc $g 617996 $s 470428
- BAS __
- $a 3
- BMC __
- $a 2007 $b 53 $c 4 $d 134-137 $i 0015-5500 $m Folia biologica (Praha) $x MED00011004
- LZP __
- $a 2007-23/mkmv